Jun 1, 2022
FDA Withdraws Approval for TG Therapeutics Cancer Treatment
The U.S. Food and Drug Administration said on Wednesday it has withdrawn its approval for TG Therapeutics Inc.'s lymphatic cancer treatment Ukoniq over concerns of higher risk of death in patients receiving the drug. Ukoniq received accelerated approval in the ...
NEXT EPISODE
PREVIOUS EPISODE